| 000 | 00987 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511151745.0 | ||
| 264 | 0 | _c19770129 | |
| 008 | 197701s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1976.tb03727.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, D A | |
| 245 | 0 | 0 |
_aAssessment of drugs in schizophrenia. Discussion on diagnosis and patient selection. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJun 1976 |
||
| 300 |
_a371-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aSchizophrenia _xdiagnosis |
| 650 | 0 | 4 | _aTime Factors |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 3 _gno. 3 Suppl 2 _gp. 371-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1976.tb03727.x _zAvailable from publisher's website |
| 999 |
_c802502 _d802502 |
||